Mary Rinella to Receptors, CCR2
This is a "connection" page, showing publications Mary Rinella has written about Receptors, CCR2.
Connection Strength
0.045
-
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial. Contemp Clin Trials. 2020 01; 88:105889.
Score: 0.045